| | 89785-84-2 Basic information More.. |
| Product Name: | Tazobactam sodium | | Synonyms: | TAZOBACTAM SODIUM;TAZOBACTAM SODIUM SALT;2-alpha-methyl-2-beta-(1,2,3-triazol-1-ylmethyl)penam-3-alpha-carboxylicacid;3-methyl-7-oxo-3-(1h-1,2,3-triazol-1-ylmethyl)-,4,4-dioxide,sodiumsalt,(2s-(2-alpha,3-beta,5-alp4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicaci;4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylicacid,3-methyl-7-oxo-3-(1h-1,2,3;cl307579;[2s-(2α,3β,5α)]-3-methyl-7-oxo-3(1h,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide;CL-298741, YTR-830H, [2S-(2α, 3β, 5α)]-3-Methyl-7-oxo-3(1H,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide | | CAS: | 89785-84-2 | | MF: | C10H12N4NaO5S | | MW: | 323.28 | | EINECS: | 685-629-4 | | Mol File: | 89785-84-2.mol |  |
Use
Tazobactam sodium is a new triazolylmethyl beta-lactamase inhibitor launched in
combination with the antibiotic piperacillin as tazocilline. Tazobactam sodium is
active against penicillinases and wide spectrum of beta-lactamases. The combination
product tazobactdpiperacillin is effective against a broad range of both
Gram-positive and -negative organisms and is indicated for the treatment of lower
respiratory tract, urinary tract, intra-abdominal, biliary and skin and soft tissue
infections. It is expected to compete against the combination product augmentin
(amoxicillidclavulanate).
- Tazobactam sodium
-
- US $0.00 / KG
- 2025-09-03
- CAS:89785-84-2
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 500kg
- Tazobactam sodium
-
- US $0.00 / KG
- 2025-08-08
- CAS:89785-84-2
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Tazobactam sodium
-
- US $0.00-0.00 / Kg/Bag
- 2025-07-11
- CAS:89785-84-2
- Min. Order: 1Kg/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
|
|
89785-84-2
Recommend Suppliers |
|